TICKERNOMICS Sign up
Last Update: 2024-12-27 15:30:02
Azitra Inc. ( AZTR )
0.41USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-98.72%
AZTR
SPY
32.66%
AZTR
0.00%
SPY
108.59%
AZTR
0.00%
SPY
302.52%
AZTR
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
2.37
-4.28
0.26
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.26
4.76
0.29
-1992.52
0.00
0.38
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-39056.09
-1419.20
-9890.26
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-229.19
-271.47
0.00
Other Earnings and Cash Flow Stats:
Azitra Inc. ( AZTR ) Net Income TTM ($MM) is -9.03
Azitra Inc. ( AZTR ) Operating Income TTM ($MM) is -11.13
Azitra Inc. ( AZTR ) Owners' Earnings Annual ($MM) is 0.00
Azitra Inc. ( AZTR ) Current Price to Owners' Earnings ratio is 0.00
Azitra Inc. ( AZTR ) EBITDA TTM ($MM) is -10.77
Azitra Inc. ( AZTR ) EBITDA Margin is -9890.26%
Capital Allocation:
Azitra Inc. ( AZTR ) has paid 0.00 dividends per share and bought back -5.411096 million shares in the past 12 months
Azitra Inc. ( AZTR ) has reduced its debt by 0.3016 million USD in the last 12 months
Capital Structure:
Azitra Inc. ( AZTR ) Interest-bearing Debt ($MM) as of last quarter is 0
Azitra Inc. ( AZTR ) Annual Working Capital Investments ($MM) are -1
Azitra Inc. ( AZTR ) Book Value ($MM) as of last quarter is 8
Azitra Inc. ( AZTR ) Debt/Capital as of last quarter is 7%
Other Balance Sheet Stats:
Azitra Inc. ( AZTR ) has 7 million in cash on hand as of last quarter
Azitra Inc. ( AZTR ) has 1 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Azitra Inc. ( AZTR ) has 5 common shares outstanding as of last quarter
Azitra Inc. ( AZTR ) has 0 million USD of preferred stock value
Academic Scores:
Azitra Inc. ( AZTR ) Altman Z-Score is -10.17 as of last quarter
Azitra Inc. ( AZTR ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Azitra Inc. ( AZTR ) largest shareholder is owning shares at 0.00 ($MM) value
Staskey Norm(an insider) Bought 47600 shares of Azitra Inc. ( AZTR ) for the amount of $10034.08 on 2024-03-29
10.70% of Azitra Inc. ( AZTR ) is held by insiders, and 8.92% is held by institutions
Azitra Inc. ( AZTR ) went public on 2023-06-16
Other Azitra Inc. ( AZTR ) financial metrics:
FCF:-10.52
Unlevered Free Cash Flow:0.00
EPS:-0.69
Operating Margin:-39056.09
Gross Profit Margin:-1419.20
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-50.11
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Azitra Inc. ( AZTR ) :
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.